Antiviral activity of diterpenes isolated from the Brazilian marine alga Dictyota menstrualis against human immunodeficiency virus type 1 (HIV-1)

Antiviral Research

Volumn 64, Issue 1, 2004, Pages 69-76

  Pereira, H S ^a,b   Leao Ferreira L R ^a   Moussatche N ^b   Teixeira, V L ^a   Cavalcanti, D N ^a   Costa, L J ^c   Diaz, R ^c   Frugulhetti, I C P P ^a  

^a FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Antivirals; Dictyota menstrualis; Diterpenes; HIV 1; HIV 1 reverse transcriptase; HIV 1 RT

Indexed keywords

DITERPENE; PROTEINASE; RNA DIRECTED DNA POLYMERASE; VIRUS DNA;

ALGA; ANTIVIRAL ACTIVITY; ARTICLE; BRAZIL; CULTURE MEDIUM; DNA SEQUENCE; DNA SYNTHESIS; ENZYME ASSAY; EVALUATION; GENE AMPLIFICATION; GENETIC CODE; GENOME; HOST CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; INCUBATION TIME; MARINE ENVIRONMENT; PRIORITY JOURNAL; REVERSE TRANSCRIPTION; VIRUS ADSORPTION; VIRUS INFECTION; VIRUS INHIBITION; VIRUS REPLICATION;

ADSORPTION; ALGAE, BROWN; ANTI-HIV AGENTS; BRAZIL; CELL LINE; DITERPENES; DNA, VIRAL; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; MOLECULAR STRUCTURE; PROVIRUSES; REVERSE TRANSCRIPTASE INHIBITORS; VIRUS REPLICATION;

ALGAE; DICTYOTA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 4644262497     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.antiviral.2004.06.006     Document Type: Article

References (30)

1. C. Aiken, and D. Trono Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis J. Virol. 69 1995 5048 5056
2. M.L. Barreca, A. Chimirri, E. De Clercq, L. De Luca, A.M. Monforte, P. Monforte, A. Rao, and M. Zappala Anti-HIV agents: design and discovery of new potent RT inhibitors IL Farmaco. 58 2003 259 263
3. L. Biesert, F. Zimmermann, B. Schroder, E. Matthes, H. Suhartono, U. Dietrich, and H. Rubsamen-Waigmann Biochemical and genetical analysis of AZT-resistant HIV-mutants Behring Inst. Mitt. 1991 74 80
4. J.H. Cardellina II, M.H. Munro, R.W. Fuller, K.P. Manfredi, T.C. McKee, M. Tischler, H.R. Bokesch, K.R. Gustafson, J.A. Beutler, and M.R. Boyd A chemical screening strategy for the dereplication and prioritization of HIV-inhibitory aqueous natural products extracts J. Nat. Prod. 56 1993 1123 1129
5. E. De Clercq Current lead natural products for the chemotherapy of human immunodeficiency virus (HIV) infection Med. Res. Rev. 20 2000 323 349
6. R.S. Fletcher, G. Holleschak, E. Nagy, D. Arion, G. Borkow, Z.W. Gu, M.A. Wainberg, and M.A. Parniak Single-step purification of recombinant wild-type and mutant HIV-1 reverse transcriptase Protein Expr. Purif. 7 1996 27 32
7. T. Fujioka, Y. Kashiwada, R.E. Kilkuskie, L.M. Cosentino, L.M. Ballas, J.B. Jiang, W.P. Janzen, I.S. Chen, and K.H. Lee Anti-AIDS agents, 11. Betulinic acid and platanic acid as anti-HIV principles from Syzigium claviflorum, and the anti-HIV activity of structurally related triterpenoids J. Nat. Prod. 57 1994 243 247
8. A. Hizi, C. McGill, and S.H. Hughes Expression of soluble, enzymatically active, human immunodeficiency virus reverse transcriptase in Escherichia coli and analysis of mutants Proc. Natl. Acad. Sci. U.S.A. 85 1988 1218 1222
9. P. Huang, D. Farquhar, and W. Plunkett Selective action of 2′,3′-didehydro-2′,3′-dideoxythymidine triphosphate on human immunodeficiency virus reverse transcriptase and human DNA polymerases J. Biol. Chem. 267 1992 2817 2822
10. M. Jung, S. Lee, and H. Kim Recent studies on natural products as anti-HIV agents Curr. Med. Chem. 7 2000 649 661
11. Y. Kashiwada, F. Hashimoto, L.M. Cosentino, C.H. Chen, P.E. Garrett, and K.H. Lee Betulinic acid and dihydrobetulinic acid derivatives as potent anti-HIV agents J. Med. Chem. 39 1996 1016 1017
12. S. Loya, A. Rudi, R. Tal, Y. Kashman, Y. Loya, and A. Hizi 3,5,8-Trihydroxy-4-quinolone, a novel natural inhibitor of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2 Arch. Biochem. Biophys. 309 1994 315 322
13. S. Loya, A. Rudi, Y. Kashman, and A. Hizi Mode of inhibition of HIV-1 reverse transcriptase by polyacetylenetriol, a novel inhibitor of RNA- and DNA-directed DNA polymerases Biochem. J. 362 2002 685 692
14. G.M. Lucas, R.E. Chaisson, and R.D. Moore Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions Ann. Intern. Med. 131 1999 81 87
15. P. Lusso, F. Cocchi, C. Balotta, P.D. Markham, A. Louie, P. Farci, R. Pal, R.C. Gallo, and M.S. Reitz Jr. Growth of macrophage-tropic and primary human immunodeficiency virus type 1 (HIV-1) isolates in a unique CD4+ T-cell clone (PM1): failure to downregulate CD4 and to interfere with cell-line-tropic HIV-1 J. Virol. 69 1995 3712 3720
16. J.F. Mayaux, A. Bousseau, R. Pauwels, T. Huet, Y. Henin, N. Dereu, M. Evers, F. Soler, C. Poujade, E. De Clercq, and J.B. Le Pecq Triterpene derivatives that block entry of human immunodeficiency virus type 1 into cells Proc. Natl. Acad. Sci. U.S.A. 91 1994 3564 3568
17. L. Menendez-Arias Targeting HIV: antiretroviral therapy and development of drug resistance Trends Pharmacol. Sci. 23 2002 381 388
18. V.J. Merluzzi, K.D. Hargrave, M. Labadia, K. Grozinger, M. Skoog, J.C. Wu, C.K. Shih, K. Eckner, S. Hattox, J.R. Adams, R. Faanes, R.J. Eckner, R.A. Koup, and J.L. Sullivan Inhibition of HIV-1 replication by a nonnucleoside reverse transcriptase inhibitor Science 250 1990 1411 1413
19. I. Najera, D.D. Richman, I. Olivares, J.M. Rojas, M.A. Peinado, M. Perucho, R. Najera, and C. Lopez-Galindez Natural occurrence of drug resistance mutations in the reverse transcriptase of human immunodeficiency virus type 1 isolates AIDS Res. Hum. Retroviruses 10 1994 1479 1488
20. M. Ninomya, S. Matsuka, A. Kawakubo, and N. Bito HIV-1 reverse transcriptase inhibitors containing hydroxydityodial ordictyodial Jpn. Kokai Tokkyo Koho JP 285 1995 877
21. H.J. Phillips Dye exclusion tests for cell virology P.F. Kruse M.K. Patterson Jr. Tissue Culture. Methods and Applications 1973 Academic Press Inc. New York 406 407
22. A. Ramos, A. Tanuri, M. Schechter, M.A. Rayfield, D.J. Hu, M.C. Cabral, C.I. Bandea, J. Baggs, and D. Pieniazek Dual and recombinant infections: an integral part of the HIV-1 epidemic in Brazil Emerg. Infect. Dis. 5 1999 65 74
23. D. Richman, A.S. Rosenthal, M. Skoog, R.J. Eckner, T.C. Chou, J.P. Sabo, and V.J. Merluzzi BI-RG-587 is active against zidovudine-resistant human immunodeficiency virus type 1 and synergistic with zidovudine Antimicrob. Agents Chemother. 35 1991 305 308
24. C. Sergheraert, C. Pierlot, A. Tartar, Y. Henin, and M. Lemaitre Synthesis and anti-HIV evaluation of D4T and D4T 5′-monophosphate prodrugs J. Med. Chem. 36 1993 826 830
25. M.H. St. Clair, J.L. Martin, G. Tudor-Williams, M.C. Bach, C.L. Vavro, D.M. King, P. Kellam, S.D. Kemp, and B.A. Larder Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase Science 253 1991 1557 1559
26. L. Stuyver, A. Wyseur, A. Rombout, J. Louwagie, T. Scarcez, C. Verhofstede, D. Rimland, R.F. Schinazi, and R. Rossau Line probe assay for rapid detection of drug-selected mutations in the human immunodeficiency virus type 1 reverse transcriptase gene Antimicrob. Agents Chemother. 41 1997 284 291
27. V.L. Teixeira, D.N. Cavalcanti, and R.C. Pereira Chemotaxonomic study of the diterpenes from the brown alga Dictyota menstrualis Biochem. Syst. Ecol. 29 2001 313 316
28. J. Tozser HIV inhibitors: problems and reality Ann. N.Y. Acad. Sci. 946 2001 145 159
29. B.G. Turner, and M.F. Summers Structural biology of HIV J. Mol. Biol. 285 1999 1 32
30. J.C. Wu, M. Chernow, R.E. Bochme, R.T.M. Suttmann, M.J. McRoberts, E.J. Prisbe, T.R. Mattews, P.A. Marx, R.Y.C. Chuang, and M.S. Chen Kinetics and inhibition of reverse transcriptase from human and simian immunodeficiency viruses Antimicrob. Agents Chemother. 32 1988 1887 1890